InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: None

Monday, 04/04/2016 9:09:25 AM

Monday, April 04, 2016 9:09:25 AM

Post# of 18784
STICKY ALERT:

This is patently false information. You have posted this (and stickied it before). It has been corrected before. You need to read the F-R rule and understand it. It does not determine the pps of a stock. Rather it sets the market cap level which a drug coompany should have in order to have a positive Phase III outcome, ie $300M. AEZS current market cap is ( Market Cap 33.10M). Hence according to the F-R rule the 2 Phase III's have tremendous odds of failure.

F-R rule shows a company with less than $300M market cap has never had a successful cancer Phase III. AEZS market cap is ~$10M.

Quoting from an article:

________________________________________________________

The Feuerstein-Ratain Rule Update: Still Perfect Predicting Small-Cap Cancer Drug Failure

A market cap under $300 million forecasts phase III study failure.

"Sure. When Dr. Mark Ratain and I came up with the concept for the F-R Rule in 2011, we were limited to analyzing a data set of 59 phase III oncology clinical trials conducted between 2000 and 2009.
For the update, I asked the research staff at BioMedTracker to help me bridge the gap between the initial analysis and the present by compiling a new list of phase III oncology phase III studies conducted from 2009 through February 2014. BioMedTracker delivered to me a list of 72 oncology phase III trials.

-- Twenty-eight of the 72 studies were positive -- a success rate of 39%.

-- Forty-two studies were negative -- a failure rate of 58%. Results for two of the studies could not be determined.



Since that article there has been an exception. Feuerstein tweets:

_______________________________________________
Adam Feuerstein ?@adamfeuerstein Mar 15
$CPXX Surprises With Blood Cancer Drug Survival Benefit http://www.thestreet.com/story/13494703/1/celator-pharma-surprises-with-blood-cancer-drug-survival-benefit.html … A Feuerstein-Ratain Rule exception!
_______________________________________________


Can't believe anyone would use Feuerstein to support AEZS. If you follow his tweets you will note that for approximately 4 years he has referred to AEZS as sxxx.

https://twitter.com/adamfeuerstein

________________________________________________________

(I have no shares)

AEZS

Find your trading edge on E*TRADE Pro.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News